An F.D.A. panel recommends the Pfizer-BioNTech vaccine for young children.
Federal officials hope the pediatric dose for children age 5 to 11 can help close a major gap in the nation’s vaccine campaign that has worried parents, educators and public health leaders.
October 26, 2021 • Sharon Otterman, Joseph Goldstein, Sharon LaFraniere, Noah Weiland